BALAXI PHARMACEUTICALS
Back to Balance Sheet
|
BALAXI PHARMACEUTICALS Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Deferred Tax Assets / Liabilities | ₹0.90 Cr | ₹1.00 Cr | ₹1.10 Cr | ₹0.04 Cr | ₹0.01 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of BALAXI PHARMACEUTICALS ?
| Year | Deferred Tax Assets / Liabilities |
|---|---|
| Mar2025 | ₹0.90 Cr |
| Mar2024 | ₹1.00 Cr |
| Mar2023 | ₹1.10 Cr |
| Mar2022 | ₹0.04 Cr |
| Mar2021 | ₹0.01 Cr |
How is Deferred Tax Assets / Liabilities of BALAXI PHARMACEUTICALS Trending?
| Years | Deferred Tax Assets / Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹0.90 Cr | -9.55 | |
| Mar2024 | ₹1.00 Cr | -9.63 | |
| Mar2023 | ₹1.10 Cr | 2,723.08 | |
| Mar2022 | ₹0.04 Cr | 457.14 | |
| Mar2021 | ₹0.01 Cr | - | |
Compare Deferred Tax Assets / Liabilities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹156.8 Cr | 2.1% | -25.3% | -61.5% | Stock Analytics | |
| ADANI ENTERPRISES | ₹288,507.0 Cr | -0.3% | -3.7% | -2.2% | Stock Analytics | |
| REDINGTON | ₹21,197.8 Cr | -0.3% | -5.7% | 33.5% | Stock Analytics | |
| MMTC | ₹9,631.5 Cr | 16.2% | 4.8% | -21.1% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹9,547.1 Cr | -11.7% | 7.5% | 63.2% | Stock Analytics | |
| HONASA CONSUMER | ₹8,742.7 Cr | -0.6% | -8.4% | 8.8% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | 2.1% |
-25.3% |
-61.5% |
| SENSEX | 0.7% |
0.5% |
9% |
You may also like the below Video Courses